Depicting the composition of gut microbiota in children with tic disorders: an exploratory study

• Published in: Journal of child psychology and psychiatry Vol. 62; no. 10; pp. 1246 - 1254
• Main Authors: Xi, Wenjie, Gao, Xuefeng, Zhao, Huijun, Luo, Xi, Li, Jianfeng, Tan, Xinjie, Wang, Lei, Zhao, Jian‐Bo, Wang, Jing, Yang, Guang, Liu, Li‐Ying, Wang, Yang‐Yang, Peng, Lihua, Zou, Li‐Ping, Yang, Yunsheng
• Format: Journal Article
• Language: English
• Published: England Blackwell Publishing Ltd 01.10.2021
• Subjects: Bacteria; Child & adolescent psychiatry; Children; Control Groups; Degradation; Dopamine; dopamine receptor antagonists; Escherichia coli; Gamma-aminobutyric acid; Gut microbiota; Hostility; metabolic pathways; Metabolism; metagenomics; Microbiology; Microbiota; Multivariate analysis; Narcotics; Neurotransmitters; Pathogens; Streptococcus infections; Termites; Tic disorders; Tics; dopamine receptor antagonists; Tic disorders; metagenomics; gut microbiota; metabolic pathways
• ISSN: 0021-9630; 1469-7610; 1469-7610
• DOI: 10.1111/jcpp.13409

Background Symptom improvement in children with tic disorder (TD) following fecal microbiota transplantation led us to investigate the gut microbiota in TD. This exploratory study aims to depict the gut microbial profile in patients with TD and explore the impact of dopamine receptor antagonist (DRA) drugs on the composition and metabolic function of the gut microbiota. Methods The gut microbiota were profiled in fecal samples of 49 children with TD and 50 matched healthy controls (HC) using shotgun metagenomic sequencing. A random forest (RF) model was constructed using the gut bacterial species to distinguish TD from HC. Associations between clinical metadata and microbial abundance or function were analyzed using MaAsLin2 and Spearman correlation. Results The gut microbiota in children with TD was featured by higher abundances of Bacteroides plebeius and Ruminococcus lactaris (a potential pro‐inflammatory taxon) and lower abundances of Prevotella stercorea and Streptococcus lutetiensis compared to HC. The constructed RF model accurately distinguished TD from HC based on the gut microbiota profile, resulting in an AUC of 0.884. Significant correlations were observed between tic symptom severity and the abundances of multiple bacterial species and gut microbiota metabolic functions. Multivariate analysis identified an upregulation of 4‐aminobutanoate (GABA) degradation in the gut microbiota associated with TD status. The gut microbiota of DRA‐treated TD children showed a distinct gut microbiota compared to the treatment‐naïve group, represented by an increase in some potential enteric pathogens such as Escherichia coli, a decline in several species including Akkermansia muciniphila, and alterations in various metabolic functions. Conclusions Bacterial species promoting inflammatory responses and those modulating neurotransmitters such as GABA may be involved in the pathogenesis of TD. The use of DRA drugs is likely to induce overgrowth of some enteric pathogens and alter the gut microbiota metabolism.